SESSION 12. REGULATORY ASPECTS FOR IMPLEMENTING ARTIFICIAL INTELLIGENCE IN PV

Governance of artificial intelligence and machine learning in pharmacovigilance: what works today and what more is needed? (Award - EUPV congress 2025)
November, Thursday 20 | 14:30 - 14:55

Speakers

RORY LITTLEBURY
GSK - Head of PV System Oversight and QPPV Office
MICHAEL GLASER
GSK - Safety Innovation Technology Director